A jury in June found that Dr. Adams submitted false claims for chelation therapy reimbursements, according to a news release. Medicare reimbursed Dr. Adams for more than $1.1 million for the therapy, which is designed to remove heavy metals from the body.
However, Dr. Adams falsely claimed his patients had heavy metal poisoning in his submissions to Medicare.
The case first came to light when Dr. Adams faced a civil complaint alleging he submitted the false claims between November 2008 and September 2015.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
